Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lutathera
Pharma
Novartis charts next US investment with new radiopharma plant
As Novartis kicks off the new year, the Swiss drugmaker is elaborating further on plans for the $23 billion U.S. investment it unveiled last April.
Fraiser Kansteiner
Jan 9, 2026 10:30am
CHMP signs off on GSK's comeback ADC cancer drug Blenrep
May 23, 2025 11:23am
Novartis filed patent lawsuits in defense of radiopharma meds
Nov 4, 2024 10:48am
Novartis brings isotope production in house amid global shortage
Sep 4, 2024 11:24am
Novartis eyes $1B Lutathera acceleration with first-line win
Jan 19, 2024 10:00am
Novartis commits $85M to build radiotherapy plant in China
Dec 1, 2023 11:06am
